InsiderSignal.AI

InsiderSignal.ai

TEM - Tempus Ai, Inc.

Insider Sale by Fukushima Ryan (CEO, Data)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

2 days ago, Fukushima Ryan, serving as CEO, Data at Tempus Ai, Inc. (TEM), sold 9,592 shares at $59.05 per share, for a total transaction value of $566,408.00. Following this transaction, Fukushima Ryan now holds 918,155 shares of TEM.

This sale represents a 1.00% decrease in Fukushima Ryan's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, February 19, 2026 and publicly disclosed via SEC Form 4 filing on Friday, February 20, 2026, 1 day after the trade was made.

Tempus Ai, Inc. operates in the HEALTHCARE sector, specifically within the HEALTH INFORMATION SERVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Fukushima Ryan

CEO, Data

Ryan Fukushima is the Chief Operating Officer (COO) of Tempus AI, Inc. (NASDAQ: TEM), a position he has held since September 2015 as part of the company's founding team, helping build it from inception to a leading precision medicine platform leveraging AI for healthcare insights and personalized treatments.[[1]](https://fintool.com/app/research/companies/TEM/people/ryan-fukushima)[[2]](https://www.tempus.com/team_members/ryan-fukushima/)[[4]](https://ryanfukushima.substack.com/about) Age 39, Fukushima recently sold shares in Tempus AI, including 5,000 shares on January 5, 2026, for $321,300 under a Rule 10b5-1 plan, and previously 20,000 shares in June 2025, while retaining significant holdings.[[3]](https://www.investing.com/news/insider-trading-news/fukushima-tempus-ai-coo-sells-321k-in-shares-93CH-4436039)[[7]](https://www.marketbeat.com/instant-alerts/ryan-fukushima-sells-5000-shares-of-tempus-ai-nasdaqtem-stock-2026-01-07/)[[8]](https://id.tradingview.com/news/tradingview:65f658a3b623b:0-tempus-ai-coo-ryan-fukushima-sells-20-000-shares/) Fukushima earned a B.S. in Engineering from California Polytechnic University and an MBA from the University of Michigan's Ross School of Business, where he was a Zell Scholar.[[1]](https://fintool.com/app/research/companies/TEM/people/ryan-fukushima)[[2]](https://www.tempus.com/team_members/ryan-fukushima/) His career includes prior roles as Entrepreneur-in-Residence and Vice President at Lightbank LLC (2014-2015), focusing on enterprise software investments, and at Hyde Park Venture Partners on Midwest enterprise deals; earlier, he engineered backend systems for Cisco and VMware.[[2]](https://www.tempus.com/team_members/ryan-fukushima/) He currently serves as CEO and director of Pathos AI, Inc., a biotech firm using AI and real-world data for precision medicines, with his Tempus compensation prorated for external commitments.[[1]](https://fintool.com/app/research/companies/TEM/people/ryan-fukushima)[[4]](https://ryanfukushima.substack.com/about)[[6]](https://www.genialis.com/2025/02/26/reinventing-diagnostics-the-superpower-of-not-knowing-what-cant-be-done-tpm-podcast-43/)

View full insider profile →

Trade Price

$59.05

Quantity

9,592

Total Value

$566,408.00

Shares Owned

918,155

Trade Date

Thursday, February 19, 2026

2 days ago

SEC Filing Date

Friday, February 20, 2026

Filed 1 day after trade

HEALTHCAREHEALTH INFORMATION SERVICES

About Tempus Ai, Inc.

Company Overview

No company information available
View news mentioning TEM

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4156157

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime